首页 > 市场调查报告书 > 製药

处方药

市场调查报告书

商品编码

1791244

五氟利多市场报告：2031 年趋势、预测与竞争分析

Penfluridol Market Report: Trends, Forecast and Competitive Analysis to 2031

出版日期: 2025年08月14日 | 出版商:

Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录图表

全球五氟利多市场前景光明，医院、诊所和药局市场都蕴藏着巨大的机会。预计2025年至2031年期间，全球五氟利多市场的复合年增长率将达到2.1%。该市场的主要驱动力包括思觉失调症患者数量的增加、对长期抗精神病药物需求的不断增长，以及对精神健康治疗的日益关注。

Lucintel 预测，在预测期内，锭剂将成为成长最快的类型。
以用途类型来看，医院预计将出现最高的成长。
按地区划分，预计亚太地区将在预测期内实现最高成长。

一份全面的 150 多页报告提供了宝贵的见解，为您的业务决策提供参考。

五氟利多市场的新趋势

五氟利多市场受到许多新趋势的影响，这些新趋势超越了其作为抗精神病药物的传统用途，受到新研究发现（特别是药物再利用）以及对精神健康治疗中有效、方便、长效治疗方案的持续需求的推动。

肿瘤学药物再利用：五氟利多在癌症治疗中的再利用正在迅速增加。研究表明，它透过不同的机制在包括乳癌、神经胶母细胞瘤细胞株中表现出抗肿瘤活性，使其成为潜在的新型抗癌药物。
基于奈米粒子的递送系统：基于奈米粒子的递送系统正在用于五氟利多的研究，此举旨在提高生物有效性，促进靶向递送，并扩大其用途，特别是在常规製剂无效的难治性病例中。
口服长效依从性重点：五氟利多是一种每週口服一次的长效抗精神病药，在提高依从性方面越来越受到关注，尤其是对于拒绝注射长效製剂的患者。
原料药生产和出口成长：五氟利多原料药的生产和出口正在上升，尤其是来自印度和中国等国家。
智慧财产权和生物相似药活动：五氟利前驱药物的专利申请数量不断增加反映了持续的研发投入，表明随着关键专利的成熟，生物相似药和学名药之间可能会存在竞争，从而影响市场动态和准入。

这些趋势正在重新定义五氟利多的市场，显着拓展其在传统抗精神病药物以外的治疗应用，尤其是在肿瘤治疗领域。创新的给药机制、更强的口服依从性、全球化的原料药生产以及对智慧财产权活动的重视，为这种成熟药物带来了令人兴奋的新机会。

五氟利多市场的最新趋势

儘管五氟利多市场已经成熟，但仍面临一些新兴趋势，这些趋势将影响其用途和未来发展潜力。这些趋势的驱动因素包括：即将进行的针对新型治疗用途（尤其是在肿瘤学领域）的研究，以及国际药品生产和分销的变化。

发现抗癌活性：在各种癌细胞细胞株中发现五氟利多具有强大的抗肿瘤活性，激发了人们对肿瘤学领域药物再利用的研究兴趣。
原料药产量成长：五氟利多原料药(API) 的製造和出口显着成长，尤其是来自印度和中国，瞄准国际非专利市场并增加其供应。
奈米粒子递送系统研究：目前正在研究基于奈米粒子的递送系统，以提高五氟利多的疗效并在难治性疾病中寻找新的应用。
前驱药物专利申请：过去几年，五氟利前驱药物专利申请的增加反映了对研发的持续支出，并表明了人们对改善药理特性和市场独占性的兴趣。
在抗治疗性思觉失调症中的作用：在多个市场上都有临床和现实世界的证据支持五氟利多对抗治疗性思觉失调症特定患者群体的疗效，从而推动了对这种专门适应症的需求。

这些重要进展正在对五氟利多市场产生重大影响，为其在肿瘤治疗中作为抗精神病药物的传统用途开闢了新的治疗可能性。原料药生产、给药技术和智慧财产权方面的创新为五氟利多带来了新的机会，有可能推动其在特定细分领域的更广泛认可和市场准入。

The future of the global penfluridol market looks promising with opportunities in the hospital, clinic, and pharmacy markets. The global penfluridol market is expected to grow with a CAGR of 2.1% from 2025 to 2031. The major drivers for this market are the increasing cases of chronic schizophrenia, the rising demand for long-term antipsychotics, and the growing focus on mental health treatment.

Lucintel forecasts that, within the type category, tablets are expected to witness higher growth over the forecast period.
Within the application category, hospitals are expected to witness the highest growth.
In terms of region, APAC is expected to witness the highest growth over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report. Sample figures with some insights are shown below.

Emerging Trends in the Penfluridol Market

The market for penfluridol is affected by a number of emerging trends that reach beyond its classic application as an antipsychotic. They are fueled by new discoveries from research, more specifically in drug repurposing, and the constant demand for effective and easy long-acting treatment solutions in mental health treatment.

Drug Repurposing in Oncology: There is a robust upsurge in the repurposing of penfluridol in cancer therapies. Studies point to its anti-tumor activity in a range of cancer cell lines such as breast, pancreatic, and glioblastoma via differing mechanisms, making it a candidate for a new anti-cancer drug.
Nanoparticle-Based Delivery Systems: Nanoparticle-based delivery systems are being researched for penfluridol. This is a trend that seeks to increase its bioavailability, facilitate targeted delivery, and possibly extend its uses, especially in refractory cases where conventional formulations are less effective.
Oral Long-Acting Adherence Focus: Penfluridol's status as an oral long-acting antipsychotic with a weekly dosing regimen is receiving increased interest for its ability to enhance patient compliance, particularly for those patients who refuse injectable long-acting preparations.
API Production and Export Growth: There is a significant trend towards the growth of penfluridol active pharmaceutical ingredient (API) production and export, particularly from nations such as India and China, due to worldwide demand for cost-efficient and dependable long-acting oral antipsychotics.
Intellectual Property and Biosimilar Activity: The upswing in filings on patents for penfluridol prodrugs reflects continued research and development investment. This implies a future trend of potential biosimilar or generic competition as major patents mature, impacting market dynamics and access.

These trends are collectively redefining the penfluridol market by vastly expanding its therapeutic application beyond its conventional antipsychotic role, especially into oncology. The emphasis on new delivery mechanisms, enhancing oral compliance, worldwide API manufacturing, and intellectual property activity indicates a vibrant landscape with fresh opportunities for this mature drug.

Recent Developments in the Penfluridol Market

The penfluridol market, though mature, is facing some recent trends that are affecting its application and potential future. These trends are mostly influenced by upcoming research into novel therapeutic uses, especially in oncology, and changes in international pharmaceutical production and distribution.

Anticancer Activity Discovery: One key development is the discovery of penfluridol's potent anti-tumor activities in different cancer cell lines, which has generated growing research interest in the oncology repurposing of drugs.
Growth in API Production: There has been appreciable growth in penfluridol active pharmaceutical ingredient (API) manufacturing and exportation, especially from India and China, targeting international generic markets and raising accessibility.
Nanoparticle Delivery Research: Current research is aimed at creating nanoparticle-based delivery systems for penfluridol with the hope of increasing its efficacy and possibly finding new uses for it in refractory conditions.
Patent Filings for Prodrugs: An increase in patent filings for penfluridol prodrugs over the past few years reflects continued research and development spending, indicating an interest in enhancing its pharmacological characteristics and providing market exclusivity.
Role in Treatment-Resistant Schizophrenia: Clinical and real-world evidence in a few markets are underpinning penfluridol's effectiveness in a niche of treatment-resistant schizophrenia patients, expanding demand for this particular indication.

These are pivotal advancements that are strongly influencing the penfluridol market by opening new potential therapeutic applications beyond its historic antipsychotic use in oncology. The innovation of API manufacturing, delivery technologies, and intellectual property suggests renewed activity in penfluridol, possibly sparking its wider acceptance and market appearance in certain niches.

Strategic Growth Opportunities in the Penfluridol Market

The penfluridol market, though mostly recognized for its antipsychotic activity, offers strategic growth opportunities through the discovery and development of its potential in new therapeutic uses. Targeting these new areas can unlock tremendous market growth and reposition the drug beyond its existing main use.

Targeting Treatment-Resistant Cancers: The development of penfluridol as a new therapeutic compound for treatment-resistant cancers, especially those where it has been demonstrated to have substantial anti-tumor effects such as glioblastoma and triple-negative breast cancer, is a significant opportunity for growth.
Adjunctive Therapy in Oncology: Exploration of penfluridol as an adjunctive therapy to augment the effectiveness of current chemotherapy or immunotherapy regimens in cancer therapy based on its synergistic anti-tumor actions.
Managing Schizophrenia Non-Adherence: Highlighting penfluridol's benefit as an oral long-acting antipsychotic for patients with poor compliance to daily oral medication or those who reject injectable long-acting formulations, offering a convenient option.
Behavioral Symptoms in Dementia: Investigating and clinically confirming penfluridol's potential in the management of severe behavioral and psychological symptoms of dementia, where its long-acting oral profile may provide advantages for patient and caregiver convenience.
New Drug Delivery for Refractory Cases: Formulating new drug delivery systems, including nanoparticle formulations, to enhance the bioavailability and targeted delivery of penfluridol for refractory cases in both its historic antipsychotic and future cancer uses.

These application-based strategic growth opportunities are affecting the penfluridol market by radically transforming its scope from conventional psychiatric applications, with a dominant focus on oncology. The investigation into adjunctive therapy, niche applications in mental health, and new delivery systems reflects an earnest attempt to take penfluridol's therapeutic value to the maximum and increase its market reach.

Penfluridol Market Driver and Challenges

The penfluridol market is affected by a distinctive combination of factors that are both major drivers for its application and significant challenges for its expansion and extensive usage. They are its pharmacological profile, economic factors, and advancing scientific findings that are reformulating its perceived value and potential.

The factors responsible for driving the penfluridol market include:

1. Long-Acting Oral Administration: An important impetus is penfluridol's long-acting oral pharmacokinetic profile, making it possible to administer once a week, significantly enhancing patient compliance to long-term medication treatment in conditions such as schizophrenia.

2. Cost-Effectiveness: Penfluridol tends to be cheaper than newer, patented long-acting injectable antipsychotics and thus becomes a cost-saving option in cost-conscious healthcare systems and for poorer patients.

3. Repurposing in Oncology: The newly emerging evidence of penfluridol's strong anti-tumor activity across different cancer cell lines has emerged as a prime driver, possibly broadening its therapeutic indications and opening up new market opportunities.

4. Established Efficacy in Schizophrenia: Although an older antipsychotic, penfluridol has established efficacy in the treatment of the positive symptoms of schizophrenia, especially for maintenance therapy, supporting its ongoing use in some clinical contexts.

5. API Production and Export: The strong active pharmaceutical ingredient (API) manufacturing base, particularly in India and China, provides a stable and low-cost supply, fueling its presence in international generic markets.

Challenges in the penfluridol market are:

1. Limited US and European Approval: Penfluridol lacks broad approval and commercialization in the US and some parts of Europe for its antipsychotic application, restricting its market penetration and recognition in these key pharmaceutical markets.

2. Newer Antipsychotics Competition: The product is subject to strong competition from newer, more extensively marketed atypical antipsychotics, particularly long-acting injectables, which tend to have a wider range of indications and a more acceptable side effect profile.

3. Side Effect Profile: As with other first-generation antipsychotics, penfluridol can be linked with extrapyramidal side effects, which can affect patient tolerability and adherence, presenting a barrier to its wider use.

The principal drivers of its long-acting oral profile, cost benefit, and new oncology uses are maintaining and potentially enhancing the penfluridol business. While challenges of its limited approval in major markets, competition from more recently approved drugs, and its side effect profile create the need for continued research and strategic positioning to maintain its relevance and therapeutic value.

List of Penfluridol Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, penfluridol companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the penfluridol companies profiled in this report include:
Hunan Dongting Pharm
Jiangsu Nhwa Pharmaceutical
Sphsine Pharm
Chongqing Qingyang Pharmaceutical
Kamp
Harbin Pharmaceutical Group
Fuhe Group
Hunan Zhongnan Pharm
Lifecare Neuro Products
Enomark

Penfluridol Market by Segment

The study includes a forecast for the global penfluridol market by type, application, and region.

Penfluridol Market by Type [Value from 2019 to 2031]:

Tablets
Capsules

Penfluridol Market by Application [Value from 2019 to 2031]:

Hospital
Clinic
Pharmacy
Others

Penfluridol Market by Region [Value from 2019 to 2031]:

North America
Europe
Asia Pacific
The Rest of the World

Country Wise Outlook for the Penfluridol Market

The penfluridol market, although niche, is witnessing changing dynamics with its novel long-acting oral profile for schizophrenia treatment and growing research into new therapeutic uses. Recent trends indicate regional differences in clinical practice, regulatory environments, and increased interest in drug repurposing. These trends are affecting manufacturing, distribution, and future potential of penfluridol.

United States: Penfluridol is not commonly approved or sold in the US. Current activity is mostly focused on the investigation of its repurposing potential in oncology, rather than on its original antipsychotic indication. The US market continues to be dominated by newer, long-acting injectables for schizophrenia.
China: China is a large producer and consumer of penfluridol, mainly for the treatment of schizophrenia. Recent news has involved regulatory approvals of new generic versions to expand availability and attempts by local producers to fulfill rising demand. In addition, research on the anti-tumor property of penfluridol has been conducted.
Germany: Penfluridol's presence in Germany is limited among other antipsychotics. Current trends emphasize its application to particular clinical niches in the case of treatment-resistant patients who have poor compliance with daily oral medication, sometimes based on clinical experience over years. Emphasis remains on more recently introduced and more commonly prescribed antipsychotics.
India: India is a key world supplier of penfluridol API and finished products, especially generic ones. Developments in recent times include the expansion of production capacity to satisfy international demand for its API and expanded domestic utilization, fueled by its cost-effectiveness and long-acting oral profile for schizophrenia treatment.
Japan: Penfluridol is represented in Japan with a special emphasis upon its long-lasting oral efficacy. New trends comprise continued clinical practice with its usage in schizophrenia as well as growth in interest within its use within the control of behavioral disturbances associated with dementia in line with a population in increased age.

Features of the Global Penfluridol Market

Market Size Estimates: Penfluridol market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.
Segmentation Analysis: Penfluridol market size by type, application, and region in terms of value ($B).
Regional Analysis: Penfluridol market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the penfluridol market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the penfluridol market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

This report answers the following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the penfluridol market by type (tablets and capsules), application (hospital, clinic, pharmacy, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

1. Executive Summary

2. Market Overview

2.1 Background and Classifications
2.2 Supply Chain

3. Market Trends & Forecast Analysis

3.1 Macroeconomic Trends and Forecasts
3.2 Industry Drivers and Challenges
3.3 PESTLE Analysis
3.4 Patent Analysis
3.5 Regulatory Environment

4. Global Penfluridol Market by Type

4.1 Overview
4.2 Attractiveness Analysis by Type
4.3 Tablets: Trends and Forecast (2019-2031)
4.4 Capsules: Trends and Forecast (2019-2031)

5. Global Penfluridol Market by Application

5.1 Overview
5.2 Attractiveness Analysis by Application
5.3 Hospital: Trends and Forecast (2019-2031)
5.4 Clinic: Trends and Forecast (2019-2031)
5.5 Pharmacy: Trends and Forecast (2019-2031)
5.6 Others: Trends and Forecast (2019-2031)

6. Regional Analysis

6.1 Overview
6.2 Global Penfluridol Market by Region

7. North American Penfluridol Market

7.1 Overview
7.2 North American Penfluridol Market by Type
7.3 North American Penfluridol Market by Application
7.4 United States Penfluridol Market
7.5 Mexican Penfluridol Market
7.6 Canadian Penfluridol Market

8. European Penfluridol Market

8.1 Overview
8.2 European Penfluridol Market by Type
8.3 European Penfluridol Market by Application
8.4 German Penfluridol Market
8.5 French Penfluridol Market
8.6 Spanish Penfluridol Market
8.7 Italian Penfluridol Market
8.8 United Kingdom Penfluridol Market

9. APAC Penfluridol Market

9.1 Overview
9.2 APAC Penfluridol Market by Type
9.3 APAC Penfluridol Market by Application
9.4 Japanese Penfluridol Market
9.5 Indian Penfluridol Market
9.6 Chinese Penfluridol Market
9.7 South Korean Penfluridol Market
9.8 Indonesian Penfluridol Market

10. ROW Penfluridol Market

10.1 Overview
10.2 ROW Penfluridol Market by Type
10.3 ROW Penfluridol Market by Application
10.4 Middle Eastern Penfluridol Market
10.5 South American Penfluridol Market
10.6 African Penfluridol Market

11. Competitor Analysis

11.1 Product Portfolio Analysis
11.2 Operational Integration
11.3 Porter's Five Forces Analysis
- Competitive Rivalry
- Bargaining Power of Buyers
- Bargaining Power of Suppliers
- Threat of Substitutes
- Threat of New Entrants
11.4 Market Share Analysis

12. Opportunities & Strategic Analysis

12.1 Value Chain Analysis
12.2 Growth Opportunity Analysis
- 12.2.1 Growth Opportunities by Type
- 12.2.2 Growth Opportunities by Application
12.3 Emerging Trends in the Global Penfluridol Market
12.4 Strategic Analysis
- 12.4.1 New Product Development
- 12.4.2 Certification and Licensing
- 12.4.3 Mergers, Acquisitions, Agreements, Collaborations, and Joint Ventures

13. Company Profiles of the Leading Players Across the Value Chain

13.1 Competitive Analysis
13.2 Hunan Dongting Pharm
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.3 Jiangsu Nhwa Pharmaceutical
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.4 Sphsine Pharm
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.5 Chongqing Qingyang Pharmaceutical
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.6 Kamp
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.7 Harbin Pharmaceutical Group
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.8 Fuhe Group
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.9 Hunan Zhongnan Pharm
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.10 Lifecare Neuro Products
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing
13.11 Enomark
- Company Overview
- Penfluridol Business Overview
- New Product Development
- Merger, Acquisition, and Collaboration
- Certification and Licensing

14. Appendix

14.1 List of Figures
14.2 List of Tables
14.3 Research Methodology
14.4 Disclaimer
14.5 Copyright
14.6 Abbreviations and Technical Units
14.7 About Us
14.8 Contact Us

简介目录图表

List of Figures

Figure 1.1: Trends and Forecast for the Global Penfluridol Market
Figure 2.1: Usage of Penfluridol Market
Figure 2.2: Classification of the Global Penfluridol Market
Figure 2.3: Supply Chain of the Global Penfluridol Market
Figure 2.4: Driver and Challenges of the Penfluridol Market
Figure 3.1: Trends of the Global GDP Growth Rate
Figure 3.2: Trends of the Global Population Growth Rate
Figure 3.3: Trends of the Global Inflation Rate
Figure 3.4: Trends of the Global Unemployment Rate
Figure 3.5: Trends of the Regional GDP Growth Rate
Figure 3.6: Trends of the Regional Population Growth Rate
Figure 3.7: Trends of the Regional Inflation Rate
Figure 3.8: Trends of the Regional Unemployment Rate
Figure 3.9: Trends of Regional Per Capita Income
Figure 3.10: Forecast for the Global GDP Growth Rate
Figure 3.11: Forecast for the Global Population Growth Rate
Figure 3.12: Forecast for the Global Inflation Rate
Figure 3.13: Forecast for the Global Unemployment Rate
Figure 3.14: Forecast for the Regional GDP Growth Rate
Figure 3.15: Forecast for the Regional Population Growth Rate
Figure 3.16: Forecast for the Regional Inflation Rate
Figure 3.17: Forecast for the Regional Unemployment Rate
Figure 3.18: Forecast for Regional Per Capita Income
Figure 4.1: Global Penfluridol Market by Type in 2019, 2024, and 2031
Figure 4.2: Trends of the Global Penfluridol Market ($B) by Type
Figure 4.3: Forecast for the Global Penfluridol Market ($B) by Type
Figure 4.4: Trends and Forecast for Tablets in the Global Penfluridol Market (2019-2031)
Figure 4.5: Trends and Forecast for Capsules in the Global Penfluridol Market (2019-2031)
Figure 5.1: Global Penfluridol Market by Application in 2019, 2024, and 2031
Figure 5.2: Trends of the Global Penfluridol Market ($B) by Application
Figure 5.3: Forecast for the Global Penfluridol Market ($B) by Application
Figure 5.4: Trends and Forecast for Hospital in the Global Penfluridol Market (2019-2031)
Figure 5.5: Trends and Forecast for Clinic in the Global Penfluridol Market (2019-2031)
Figure 5.6: Trends and Forecast for Pharmacy in the Global Penfluridol Market (2019-2031)
Figure 5.7: Trends and Forecast for Others in the Global Penfluridol Market (2019-2031)
Figure 6.1: Trends of the Global Penfluridol Market ($B) by Region (2019-2024)
Figure 6.2: Forecast for the Global Penfluridol Market ($B) by Region (2025-2031)
Figure 7.1: Trends and Forecast for the North American Penfluridol Market (2019-2031)
Figure 7.2: North American Penfluridol Market by Type in 2019, 2024, and 2031
Figure 7.3: Trends of the North American Penfluridol Market ($B) by Type (2019-2024)
Figure 7.4: Forecast for the North American Penfluridol Market ($B) by Type (2025-2031)
Figure 7.5: North American Penfluridol Market by Application in 2019, 2024, and 2031
Figure 7.6: Trends of the North American Penfluridol Market ($B) by Application (2019-2024)
Figure 7.7: Forecast for the North American Penfluridol Market ($B) by Application (2025-2031)
Figure 7.8: Trends and Forecast for the United States Penfluridol Market ($B) (2019-2031)
Figure 7.9: Trends and Forecast for the Mexican Penfluridol Market ($B) (2019-2031)
Figure 7.10: Trends and Forecast for the Canadian Penfluridol Market ($B) (2019-2031)
Figure 8.1: Trends and Forecast for the European Penfluridol Market (2019-2031)
Figure 8.2: European Penfluridol Market by Type in 2019, 2024, and 2031
Figure 8.3: Trends of the European Penfluridol Market ($B) by Type (2019-2024)
Figure 8.4: Forecast for the European Penfluridol Market ($B) by Type (2025-2031)
Figure 8.5: European Penfluridol Market by Application in 2019, 2024, and 2031
Figure 8.6: Trends of the European Penfluridol Market ($B) by Application (2019-2024)
Figure 8.7: Forecast for the European Penfluridol Market ($B) by Application (2025-2031)
Figure 8.8: Trends and Forecast for the German Penfluridol Market ($B) (2019-2031)
Figure 8.9: Trends and Forecast for the French Penfluridol Market ($B) (2019-2031)
Figure 8.10: Trends and Forecast for the Spanish Penfluridol Market ($B) (2019-2031)
Figure 8.11: Trends and Forecast for the Italian Penfluridol Market ($B) (2019-2031)
Figure 8.12: Trends and Forecast for the United Kingdom Penfluridol Market ($B) (2019-2031)
Figure 9.1: Trends and Forecast for the APAC Penfluridol Market (2019-2031)
Figure 9.2: APAC Penfluridol Market by Type in 2019, 2024, and 2031
Figure 9.3: Trends of the APAC Penfluridol Market ($B) by Type (2019-2024)
Figure 9.4: Forecast for the APAC Penfluridol Market ($B) by Type (2025-2031)
Figure 9.5: APAC Penfluridol Market by Application in 2019, 2024, and 2031
Figure 9.6: Trends of the APAC Penfluridol Market ($B) by Application (2019-2024)
Figure 9.7: Forecast for the APAC Penfluridol Market ($B) by Application (2025-2031)
Figure 9.8: Trends and Forecast for the Japanese Penfluridol Market ($B) (2019-2031)
Figure 9.9: Trends and Forecast for the Indian Penfluridol Market ($B) (2019-2031)
Figure 9.10: Trends and Forecast for the Chinese Penfluridol Market ($B) (2019-2031)
Figure 9.11: Trends and Forecast for the South Korean Penfluridol Market ($B) (2019-2031)
Figure 9.12: Trends and Forecast for the Indonesian Penfluridol Market ($B) (2019-2031)
Figure 10.1: Trends and Forecast for the ROW Penfluridol Market (2019-2031)
Figure 10.2: ROW Penfluridol Market by Type in 2019, 2024, and 2031
Figure 10.3: Trends of the ROW Penfluridol Market ($B) by Type (2019-2024)
Figure 10.4: Forecast for the ROW Penfluridol Market ($B) by Type (2025-2031)
Figure 10.5: ROW Penfluridol Market by Application in 2019, 2024, and 2031
Figure 10.6: Trends of the ROW Penfluridol Market ($B) by Application (2019-2024)
Figure 10.7: Forecast for the ROW Penfluridol Market ($B) by Application (2025-2031)
Figure 10.8: Trends and Forecast for the Middle Eastern Penfluridol Market ($B) (2019-2031)
Figure 10.9: Trends and Forecast for the South American Penfluridol Market ($B) (2019-2031)
Figure 10.10: Trends and Forecast for the African Penfluridol Market ($B) (2019-2031)
Figure 11.1: Porter's Five Forces Analysis of the Global Penfluridol Market
Figure 11.2: Market Share (%) of Top Players in the Global Penfluridol Market (2024)
Figure 12.1: Growth Opportunities for the Global Penfluridol Market by Type
Figure 12.2: Growth Opportunities for the Global Penfluridol Market by Application
Figure 12.3: Growth Opportunities for the Global Penfluridol Market by Region
Figure 12.4: Emerging Trends in the Global Penfluridol Market

List of Tables

Table 1.1: Growth Rate (%, 2023-2024) and CAGR (%, 2025-2031) of the Penfluridol Market by Type and Application
Table 1.2: Attractiveness Analysis for the Penfluridol Market by Region
Table 1.3: Global Penfluridol Market Parameters and Attributes
Table 3.1: Trends of the Global Penfluridol Market (2019-2024)
Table 3.2: Forecast for the Global Penfluridol Market (2025-2031)
Table 4.1: Attractiveness Analysis for the Global Penfluridol Market by Type
Table 4.2: Market Size and CAGR of Various Type in the Global Penfluridol Market (2019-2024)
Table 4.3: Market Size and CAGR of Various Type in the Global Penfluridol Market (2025-2031)
Table 4.4: Trends of Tablets in the Global Penfluridol Market (2019-2024)
Table 4.5: Forecast for Tablets in the Global Penfluridol Market (2025-2031)
Table 4.6: Trends of Capsules in the Global Penfluridol Market (2019-2024)
Table 4.7: Forecast for Capsules in the Global Penfluridol Market (2025-2031)
Table 5.1: Attractiveness Analysis for the Global Penfluridol Market by Application
Table 5.2: Market Size and CAGR of Various Application in the Global Penfluridol Market (2019-2024)
Table 5.3: Market Size and CAGR of Various Application in the Global Penfluridol Market (2025-2031)
Table 5.4: Trends of Hospital in the Global Penfluridol Market (2019-2024)
Table 5.5: Forecast for Hospital in the Global Penfluridol Market (2025-2031)
Table 5.6: Trends of Clinic in the Global Penfluridol Market (2019-2024)
Table 5.7: Forecast for Clinic in the Global Penfluridol Market (2025-2031)
Table 5.8: Trends of Pharmacy in the Global Penfluridol Market (2019-2024)
Table 5.9: Forecast for Pharmacy in the Global Penfluridol Market (2025-2031)
Table 5.10: Trends of Others in the Global Penfluridol Market (2019-2024)
Table 5.11: Forecast for Others in the Global Penfluridol Market (2025-2031)
Table 6.1: Market Size and CAGR of Various Regions in the Global Penfluridol Market (2019-2024)
Table 6.2: Market Size and CAGR of Various Regions in the Global Penfluridol Market (2025-2031)
Table 7.1: Trends of the North American Penfluridol Market (2019-2024)
Table 7.2: Forecast for the North American Penfluridol Market (2025-2031)
Table 7.3: Market Size and CAGR of Various Type in the North American Penfluridol Market (2019-2024)
Table 7.4: Market Size and CAGR of Various Type in the North American Penfluridol Market (2025-2031)
Table 7.5: Market Size and CAGR of Various Application in the North American Penfluridol Market (2019-2024)
Table 7.6: Market Size and CAGR of Various Application in the North American Penfluridol Market (2025-2031)
Table 7.7: Trends and Forecast for the United States Penfluridol Market (2019-2031)
Table 7.8: Trends and Forecast for the Mexican Penfluridol Market (2019-2031)
Table 7.9: Trends and Forecast for the Canadian Penfluridol Market (2019-2031)
Table 8.1: Trends of the European Penfluridol Market (2019-2024)
Table 8.2: Forecast for the European Penfluridol Market (2025-2031)
Table 8.3: Market Size and CAGR of Various Type in the European Penfluridol Market (2019-2024)
Table 8.4: Market Size and CAGR of Various Type in the European Penfluridol Market (2025-2031)
Table 8.5: Market Size and CAGR of Various Application in the European Penfluridol Market (2019-2024)
Table 8.6: Market Size and CAGR of Various Application in the European Penfluridol Market (2025-2031)
Table 8.7: Trends and Forecast for the German Penfluridol Market (2019-2031)
Table 8.8: Trends and Forecast for the French Penfluridol Market (2019-2031)
Table 8.9: Trends and Forecast for the Spanish Penfluridol Market (2019-2031)
Table 8.10: Trends and Forecast for the Italian Penfluridol Market (2019-2031)
Table 8.11: Trends and Forecast for the United Kingdom Penfluridol Market (2019-2031)
Table 9.1: Trends of the APAC Penfluridol Market (2019-2024)
Table 9.2: Forecast for the APAC Penfluridol Market (2025-2031)
Table 9.3: Market Size and CAGR of Various Type in the APAC Penfluridol Market (2019-2024)
Table 9.4: Market Size and CAGR of Various Type in the APAC Penfluridol Market (2025-2031)
Table 9.5: Market Size and CAGR of Various Application in the APAC Penfluridol Market (2019-2024)
Table 9.6: Market Size and CAGR of Various Application in the APAC Penfluridol Market (2025-2031)
Table 9.7: Trends and Forecast for the Japanese Penfluridol Market (2019-2031)
Table 9.8: Trends and Forecast for the Indian Penfluridol Market (2019-2031)
Table 9.9: Trends and Forecast for the Chinese Penfluridol Market (2019-2031)
Table 9.10: Trends and Forecast for the South Korean Penfluridol Market (2019-2031)
Table 9.11: Trends and Forecast for the Indonesian Penfluridol Market (2019-2031)
Table 10.1: Trends of the ROW Penfluridol Market (2019-2024)
Table 10.2: Forecast for the ROW Penfluridol Market (2025-2031)
Table 10.3: Market Size and CAGR of Various Type in the ROW Penfluridol Market (2019-2024)
Table 10.4: Market Size and CAGR of Various Type in the ROW Penfluridol Market (2025-2031)
Table 10.5: Market Size and CAGR of Various Application in the ROW Penfluridol Market (2019-2024)
Table 10.6: Market Size and CAGR of Various Application in the ROW Penfluridol Market (2025-2031)
Table 10.7: Trends and Forecast for the Middle Eastern Penfluridol Market (2019-2031)
Table 10.8: Trends and Forecast for the South American Penfluridol Market (2019-2031)
Table 10.9: Trends and Forecast for the African Penfluridol Market (2019-2031)
Table 11.1: Product Mapping of Penfluridol Suppliers Based on Segments
Table 11.2: Operational Integration of Penfluridol Manufacturers
Table 11.3: Rankings of Suppliers Based on Penfluridol Revenue
Table 12.1: New Product Launches by Major Penfluridol Producers (2019-2024)
Table 12.2: Certification Acquired by Major Competitor in the Global Penfluridol Market

02-2729-4219

+886-2-2729-4219

License/价格

FAQ

五氟利多市场报告：2031 年趋势、预测与竞争分析

Penfluridol Market Report: Trends, Forecast and Competitive Analysis to 2031

目录

第一章执行摘要

第二章 市场概述

第三章：市场趋势与预测分析

第四章 全球五氟利多市场（按类型）

第五章全球五氟利多市场应用

第六章区域分析

第七章北美五氟利多市场

第八章欧洲五氟利多市场

9. 亚太地区五氟利多市场

第十章 世界其他地区的 Penfleur 市场

第十一章 竞争分析

第十二章机会与策略分析

第十三章：价值链主要企业的公司简介

第十四章 附录